Results 161 to 170 of about 41,379 (243)

Understanding Outcomes and Barriers to Community Naloxone Distribution Programs: A Cross-Sectional Survey of Naloxone Recipients in Kansas. [PDF]

Kans J Med
Huynh T, Haynes A, Okut H, Zackula R, Mayer C, Hervey K, Ablah E.   +6 more
europepmc   +1 more source

Overcoming barriers to the prescription/dispensation of take-home naloxone among French primary care professionals: a regional training initiative. [PDF]

Eur J Public Health
Aquizerate A, Duval M, Rousselet M, Jaulin E, Kuhn E, Oger AC, Nicolleau I, Pele S, Herault T, Artarit P, Laforgue EJ, Victorri-Vigneau C.   +11 more
europepmc   +1 more source

Potential Protective Effects of Naloxone in Traumatic Brain Injury Through JAK2/STAT3 Signaling Modulation. [PDF]

Life (Basel)
Youn DH, Jung H, Lee JH, Pak S, Han SW, Kim JT, Song K, Choi HR, Han GS, Kwon YS, Park JJ, Jeon JP, Lee JJ, Rhim JK.   +13 more
europepmc   +1 more source

Pharmacy-level barriers to opioid overdose prevention: availability and accessibility of naloxone and buprenorphine-naloxone in high-risk Texas counties. [PDF]

Harm Reduct J
Darouiche KG, Malik MM, Mohr MT, Hagenimana MA, Digbeu BDE, Cunningham KA, Farr NM, Dostal CR.   +7 more
europepmc   +1 more source

Naloxone Use and Outcomes in Prehospital and Emergency Department Care. [PDF]

Cureus
Ellingwood NT, McGraw M, Chandra K.
europepmc   +1 more source

Patient perspectives on buprenorphine/naloxone for chronic noncancer pain: A qualitative interview study. [PDF]

Can J Pain
Halpape K, Jorgenson D, Rogers M.
europepmc   +1 more source